Delhi AIIMS Sets up Committee for Patient Safety and Pharmacovigilance
AIIMS Treats Young Doctor Critically Injured in J&K Attack
New Delhi: In a move to enhance patient safety and strengthen pharmacovigilance, the All India Institute of Medical Sciences (AIIMS), New Delhi, has set up a dedicated committee to monitor and report adverse events related to drugs and medical devices used in patient care. This initiative aims to strengthen pharmacovigilance by systematically tracking side effects, complications, and safety issues arising during medical interventions at the institute.
The committe will collect and analyze data on adverse reactions and forward regular reports to central authorities. The goal is to identify potential safety issues with drugs and medical devices, facilitating timely regulatory actions to mitigate risks.
Also Read: AIIMS Delhi Introduces advanced surgical robot in General Surgery department
In an official statement, AIIMS highlighted that the committee would play a crucial role in overseeing the collection and evaluation of adverse event reports. These reports will be forwarded to the National Centre at the Indian Pharmacopoeia Commission (IPC) in Ghaziabad for further assessment and regulatory action. The initiative encourages doctors, nurses, and paramedical staff to actively report adverse events to the Pharmacology Department, ensuring a smooth and efficient flow of information to the appropriate national programs.
Also Read: AIIMS Satellite Centre in Ghaziabad gets 10-acre land approval
Monitoring the safety of medical treatments is a vital ethical responsibility for healthcare professionals. According to the news reports, Adverse Events Monitoring (AEM) allows medical teams to identify and report side effects, facilitating timely interventions to minimize risks and safeguard patient health. This system also benefits pharmaceutical manufacturers by helping them detect safety concerns related to drugs and medical devices, enabling them to implement necessary improvements.
